Does VISMODEGIB Cause Hepatotoxicity? 31 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Hepatotoxicity have been filed in association with VISMODEGIB (ERIVEDGE). This represents 0.4% of all adverse event reports for VISMODEGIB.
31
Reports of Hepatotoxicity with VISMODEGIB
0.4%
of all VISMODEGIB reports
2
Deaths
10
Hospitalizations
How Dangerous Is Hepatotoxicity From VISMODEGIB?
Of the 31 reports, 2 (6.5%) resulted in death, 10 (32.3%) required hospitalization, and 2 (6.5%) were considered life-threatening.
Is Hepatotoxicity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VISMODEGIB. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does VISMODEGIB Cause?
Muscle spasms (1,937)
Alopecia (1,330)
Ageusia (958)
Fatigue (899)
Dysgeusia (706)
Weight decreased (688)
Nausea (669)
Decreased appetite (662)
Death (657)
Diarrhoea (446)
What Other Drugs Cause Hepatotoxicity?
METHOTREXATE (1,917)
ACETAMINOPHEN (1,557)
LEFLUNOMIDE (829)
HYDROXYCHLOROQUINE (715)
PREDNISONE (707)
RITUXIMAB (702)
ETANERCEPT (699)
ADALIMUMAB (674)
CYCLOPHOSPHAMIDE (632)
SULFASALAZINE (613)
Which VISMODEGIB Alternatives Have Lower Hepatotoxicity Risk?
VISMODEGIB vs VITAMIN A
VISMODEGIB vs VITAMIN B
VISMODEGIB vs VITAMIN D NOS
VISMODEGIB vs VITAMINS
VISMODEGIB vs VOCLOSPORIN